221 related articles for article (PubMed ID: 16652321)
21. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
[TBL] [Abstract][Full Text] [Related]
22. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
Lesko CR; Tong W; Moore RD; Lau B
AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
[TBL] [Abstract][Full Text] [Related]
23. Modified directly observed therapy (MDOT) for injection drug users with HIV disease.
McCance-Katz EF; Gourevitch MN; Arnsten J; Sarlo J; Rainey P; Jatlow P
Am J Addict; 2002; 11(4):271-8. PubMed ID: 12584870
[TBL] [Abstract][Full Text] [Related]
24. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
Milloy MJ; Kerr T; Buxton J; Rhodes T; Krusi A; Guillemi S; Hogg R; Montaner J; Wood E
J Acquir Immune Defic Syndr; 2012 Apr; 59(4):393-9. PubMed ID: 22134149
[TBL] [Abstract][Full Text] [Related]
25. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
Ing EC; Bae JW; Maru DS; Altice FL
AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
[TBL] [Abstract][Full Text] [Related]
26. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
27. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
[TBL] [Abstract][Full Text] [Related]
28. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
30. Use of highly active antiretroviral therapy is increasing in HIV positive severe drug users.
Vallecillo G; Sanvisens A; Martinez E; Torrens M; Bolao F; Tor J; Muga R
Curr HIV Res; 2010 Dec; 8(8):641-8. PubMed ID: 21187006
[TBL] [Abstract][Full Text] [Related]
31. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
[TBL] [Abstract][Full Text] [Related]
32. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
33. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics.
Henrich TJ; Lauder N; Desai MM; Sofair AN
J Community Health; 2008 Apr; 33(2):69-77. PubMed ID: 18046634
[TBL] [Abstract][Full Text] [Related]
34. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
[TBL] [Abstract][Full Text] [Related]
35. Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial.
Lucas GM; Mullen BA; Galai N; Moore RD; Cook K; McCaul ME; Glass S; Oursler KK; Rand C
PLoS One; 2013; 8(7):e68286. PubMed ID: 23874575
[TBL] [Abstract][Full Text] [Related]
36. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
37. Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.
Berg KM; Mouriz J; Li X; Duggan E; Goldberg U; Arnsten JH
Contemp Clin Trials; 2009 Sep; 30(5):481-9. PubMed ID: 19505589
[TBL] [Abstract][Full Text] [Related]
38. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic.
Purkayastha T; Wasi F; Shuter J
AIDS Patient Care STDS; 2005 Dec; 19(12):785-93. PubMed ID: 16375610
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]